Gautam Borthakur Selected Research

B-Cell Prolymphocytic Leukemia

1/2021

Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gautam Borthakur Research Topics

Disease

148	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 09/2007
59	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 06/2004
48	Neoplasms (Cancer) 07/2022 - 09/2007
47	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 08/2007
38	Leukemia 11/2022 - 08/2008
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 05/2009
14	Philadelphia Chromosome 01/2022 - 06/2004
11	Diarrhea 01/2021 - 01/2006
11	Nausea 01/2021 - 12/2010
10	Thrombocytopenia (Thrombopenia) 01/2022 - 09/2009
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 12/2007
10	Exanthema (Rash) 01/2021 - 04/2014
10	Hematologic Neoplasms (Hematological Malignancy) 12/2017 - 07/2008
9	Primary Myelofibrosis (Myelosclerosis) 07/2022 - 08/2010
8	Acute Promyelocytic Leukemia 01/2022 - 01/2010
8	Anemia 01/2022 - 07/2010
8	Blast Crisis (Blast Phase) 01/2021 - 05/2009
7	Infections 01/2022 - 05/2012
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 03/2013
6	Residual Neoplasm 01/2021 - 02/2016
6	Vomiting 01/2021 - 12/2010
6	Fatigue 01/2021 - 08/2010
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 04/2016
5	Neutropenia 01/2021 - 09/2009
5	Disease Progression 01/2021 - 12/2010
5	Polycythemia Vera 04/2017 - 01/2004
4	Hyperbilirubinemia 01/2022 - 10/2008
4	Cytopenia 01/2021 - 09/2009
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021 - 07/2012
4	Hypertension (High Blood Pressure) 12/2020 - 01/2011
4	Mucositis 01/2019 - 10/2008
4	Fibrosis (Cirrhosis) 10/2018 - 08/2010
4	Essential Thrombocythemia 01/2017 - 01/2004
4	Hypoxia (Hypoxemia) 01/2016 - 01/2011
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021 - 02/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2019
3	Pleural Effusion (Pleural Effusions) 01/2020 - 01/2014
3	Aplastic Anemia (Anemia, Hypoplastic) 11/2018 - 05/2012
3	Hemorrhage 03/2016 - 01/2004

Drug/Important Bio-Agent (IBA)

34	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 09/2008
33	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2009
31	Imatinib Mesylate (Gleevec)FDA Link 11/2019 - 06/2004
27	venetoclaxIBA 11/2022 - 03/2014
21	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 12/2008
20	Decitabine FDA Link 01/2022 - 02/2007
19	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 04/2008
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2008
14	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2021 - 10/2009
14	Pharmaceutical PreparationsIBA 01/2021 - 03/2013
14	Clofarabine (Clolar)FDA Link 01/2021 - 09/2008
14	Dasatinib (BMS 354825)FDA Link 11/2020 - 08/2008
10	Sorafenib (BAY 43-9006)FDA Link 11/2020 - 04/2010
9	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2011
8	fludarabineIBA 12/2021 - 12/2007
8	ruxolitinibIBA 11/2021 - 11/2011
8	Phosphotransferases (Kinase)IBA 01/2019 - 09/2009
7	Lenalidomide (CC 5013)FDA Link 01/2021 - 11/2009
7	nilotinib FDA Link 01/2020 - 08/2008
6	ibrutinibIBA 12/2021 - 02/2016
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2011
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 01/2016
5	Transaminases (Aminotransferases)IBA 01/2020 - 10/2008
5	Hemoglobins (Hemoglobin)IBA 07/2018 - 06/2010
5	Vincristine (Oncovin)FDA LinkGeneric 02/2016 - 09/2010
4	Cladribine FDA LinkGeneric 11/2022 - 01/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 06/2014
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2021 - 08/2013
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 12/2012
4	InterferonsIBA 01/2021 - 09/2009
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 12/2008
4	BilirubinIBA 01/2020 - 10/2014
4	Gemtuzumab (Mylotarg)FDA Link 01/2020 - 10/2014
4	Arsenic Trioxide (Trisenox)FDA Link 01/2020 - 01/2017
4	Histone Deacetylase InhibitorsIBA 12/2017 - 01/2012
3	trametinibIBA 01/2022 - 01/2016
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 03/2007
3	CreatinineIBA 01/2022 - 01/2010
3	Rituximab (Mabthera)FDA Link 12/2021 - 12/2010
3	LigandsIBA 11/2021 - 11/2016
3	eltrombopag FDA Link 11/2021 - 11/2018
3	bcr-abl Fusion ProteinsIBA 01/2020 - 06/2004
3	ponatinibIBA 12/2019 - 09/2015
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 01/2017
3	Bortezomib (Velcade)FDA Link 07/2017 - 08/2011
3	peginterferon alfa-2a (Pegasys)FDA Link 04/2017 - 11/2009
3	ProdrugsIBA 01/2016 - 01/2011
3	obatoclaxIBA 12/2014 - 12/2008
3	NucleosidesIBA 06/2014 - 02/2012
2	mivebresibIBA 07/2022 - 01/2021
2	snake venom protein C activatorIBA 01/2022 - 01/2019
2	ARV-825IBA 01/2022 - 01/2019
2	Lysine (L-Lysine)FDA Link 01/2022 - 01/2021

Therapy/Procedure

110	Therapeutics 07/2022 - 01/2006
45	Drug Therapy (Chemotherapy) 11/2022 - 09/2007
7	Salvage Therapy 01/2021 - 10/2008
6	Induction Chemotherapy 01/2022 - 10/2009
6	Stem Cell Transplantation 09/2019 - 08/2010
5	Drug Tapering 11/2021 - 07/2010
4	Radiotherapy 01/2020 - 09/2007
3	Remission Induction 01/2021 - 12/2008